Single-cell oils as sources of nutraceutical and specialty lipids: Processing technologies and applications

Nutraceutical and Specialty Lipids and their Co-Products

Volumn , Issue , 2006, Pages 251-280

  Senanayake, S P J N ^a,b   Fichtali, Jaouad ^b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Martek Biosciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85044047151     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (111)

1. Bang, H.O., Dyerberg, J., and Hjorne, N., The composition of food consumed by Greenland Eskimos, Acta Med. Scand., 200, 59-73, 1976.
2. Bang, H.O. and Dyerberg, J., Plasma lipids and lipoproteins in Greenlandic West-coast Eskimos, Acta Med. Scand., 192, 85-94, 1972.
3. Bang, H.O. and Dyerberg, J., Lipid metabolism and ischemic heart disease in Greenland Eskimos, Adv. Nutr. Res., 3, 1-21, 1986.
4. Carlson, S.E., Arachidonic acid status of human infants: influence of gestational age at birth and diets with very long chain n-3 and n-6 fatty acids, J. Nutr., 126, 1092-1098, 1996.
5. Groom, H., Oil-rich fish, Nutr. Food Sci., Nov.-Dec., 4-8, 1993.
6. Greiner, R.C.S., Winter, J., Nathanielsz, P.W., and Brenna, J.T., Brain docosahexaenoate accretion in fetal baboons: bioequivalence of dietary α-linolenic and docosahexaenoic acids, Pediatr. Res. 42, 826-834, 1997.
7. Duque, A.G., The role of lipids in fetal brain development, Perinat. Nutr. Rep., Spring, 4-5, 1997.
8. Ghebremeskel, K., Min, Y., Crawford, M.A., Nam, J., Kim, A., Koo, J., and Suzuki, H., Blood fatty acid composition of pregnant and nonpregnant Korean women: red cells may act as a reservoir of arachidonic acid and docosahexaenoic acid for utilization by the developing fetus, Lipids, 35, 567-574, 2000.
9. Conquer, J.A. and Holub, B.J., Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects, J. Nutr., 126, 3032-3039, 1996.
10. Salem, N., Jr., Wegher, B., Mena, P., and Uauy, R., Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants, Proc. Natl. Acad. Sci. USA, 93, 49-54, 1996.
11. 13C22:6n-3 triacylglycerols, Am. J. Clin. Nutr., 64, 577-586, 1996.
12. Ackman, R.G. and Ratnayake, W.M.N., Fish oils, seal oils, esters and acids: are all forms of omega-3 intake equal?, in Health Effects of Fish and Fish Oils, Chandra, R.K., Ed., ARTS Biomedical Publishers and Distributors, St. John’s, Newfoundland, 1989, pp. 373-393.
13. Kinsella, J.E., Sources of omega-3 fatty acids in human diets, in Omega-3 Fatty Acids in Health and Disease, Lees, R.S. and Karel, M., Eds., Marcel Dekker, New York, 1990, pp. 157-200.
14. Seeds, M.C. and Bass, D.A., Regulation and metabolism of arachidonic acid, Clin. Rev. Allergy Immunol., 17, 5-26, 1999.
15. Krawczyk, T., Do infants need extra DHA, AA?, Inform, 12, 1064-1074, 2001.
16. British Nutrition Foundation, Recommendation for intakes of unsaturated fatty acids, in: Unsaturated Fatty Acids: Nutritional and Physiological Significance, Chapman and Hall, London, 1992, pp. 152-63.
17. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO) Expert Committee: Fats and Oil in Human Nutrition, Food and Nutrition Paper, Rome, 1994, p. 57.
18. FAO/WHO Joint Expert Consultation, Report of a joint expert consultation, FAO Food and Nutrition Paper 57, Rome, 1995, pp. 49-55.
19. International Society for the Study of Fatty Acids (ISSFAL) Board of Directors, Recommendations for the essential fatty acid requirements for infant formulae, ISSFAL Newsletter, 1, 4-5, 1994.
20. WHO and FAO Joint Consultation, Fats and oils in human nutrition, Nutr. Rev., 53, 202-205, 1995.
21. European Commission Scientific Committee on Food, Report of the Scientific Committee on Food on the Revision of Essential Requirements of Infant Formulae and Follow-on Formulae, Brussels, Belgium, May 18, 2003.
22. Uauy, R., Hoffman, D.R., Mena, P., Llanos, A., and Birch, E.E., Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials, J. Pediatr., 143, S17-S25, 2003.
23. Carver, J.D., Advances in nutritional modifications of infant formulas, Am. J. Clin. Nutr., 77, 1550S-1554S, 2003.
24. Institute of Medicine, Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids, National Academies Press, Washington, DC, 2002, pp. 7-1-7-69 (dietary fiber), 8-1-8-97 (fat and fatty acids).
25. Jensen, C.L., Chen, H., Fraley, J.K., Anderson, R.E., and Heird, W.C., Biochemical effects of dietary linoleic/alpha-linolenic acid ratio in term infants, Lipids, 1, 107-13, 1996.
26. Birch, E.E., Hoffman, D.R., Uauy, R., Birch, D.G., and Prestidge, C., Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants, Pediatr. Res., 44, 201-209, 1998.
27. Makrides, M., Neumann, M., Simmer, K., Pater, J., and Gibson, R., Are long-chain polyunsaturated fatty acids essential nutrients in infancy?, Lancet, 345, 1463-1468, 1995.
28. Birch, E.E., Garfield, S., Hoffman, D.R., Uauy, R., and Birch, D.G., A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants, Dev. Med. Child. Neurol., 42, 174-181, 2000.
29. Hoffman, D.R., Birch, E.E., Birch, D.G., Uauy, R., Castaneda, Y.S., Lapus, M.G., and Wheaton, D.H., Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development, J. Pediatr. Gastroenterol. Nutr., 31, 540-553, 2000.
30. Hoffman, D.R., Birch, E.E., Castaneda, Y.S., Fawcett, S.L., Birch, D.G., and Uauy, R., Dietary docosahexaenoic acid (DHA) and visual maturation in the post-weaning term infant, Invest. Opthalmol. Vis. Sci., 42, S122 (abstract), 2001.
31. Birch, E.E., Hoffman, D.R., Castaneda, Y.S., Fawcett, S.L., Birch, D.G., and Uauy, R., A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age, Am. J. Clin. Nutr., 75, 570-80, 2002.
32. Hoffman, D.R., Birch, E.E., Castaneda, Y.S., Fawcett, S.L., Wheaton, D.H., Birch, D.G., and Uauy, R., Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial, J. Pediat., 142, 669-677, 2003.
33. Horwood, L.J. and Fergusson, D.M., Breastfeeding and later cognitive and academic outcomes, Pediatrics, 101, E9, 1998.
34. Lucas, A., Morley, R., Cole, T.J., Lister, G., and Leeson-Payne, C., Breast milk and subsequent intelligence quotient in children born preterm, Lancet, 339, 261-264, 1992.
35. Willatts, P., Forsyth, J.S., DiModugno, M.K, Varma, S., and Colvin, M., Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age, Lancet, 352, 688-691, 1998.
36. Carlson, S.E., Werkman, S.H., Peeples, J.M., and Wilson, W.M., Long-chain fatty acids and early visual and cognitive development of preterm infants, Eur. J. Clin. Nutr. Suppl., 2, S27-S30, 1994.
37. Carlson, S.E., Werkman, S.H., Rhodes, P.G., and Tolley, E.A., Visual-acuity developments in healthy preterm infants: effect of marine-oil supplementation, Am. J. Clin. Nutr., 58, 35-42, 1993.
38. Werkman, S.H. and Carlson, S.E., A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until nine months, Lipids, 31, 91-7, 1996.
39. Uauy, R.D., Birch, D.G., Birch, E.E., Tyson, J.E., and Hoffamn, D.R., Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates, Pediatr. Res., 28, 485-92, 1990.
40. Smuts, C.M., Huang, M., Mundy, D., Plasse, T., Major, S., and Carlson, S.E., A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy, Obstet. Gynocol., 101, 469-479, 2003.
41. Clandinin, M.T., Chappell, J.E., Leong, S., Heim, T., Swyer, P.R., and Chance, G.W., Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements, Early Hum. Dev., 4, 121-129, 1980.
42. Farquharson, J., Cockburn, T., Patrick, W.A., Jamieson, E.C., and Logan, R.W., Infant cerebral cortex phospholipid fatty-acid composition and diet, Lancet, 340, 810-813, 1992.
43. Makrides, M., Neumann, M.A., Byard, R.W., Simmer, K., and Gibson, R.A., Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants, Am. J. Clin. Nutr., 60, 189-94, 1994.
44. Clark, K.J., Makrides, M., Neumann, M.A., and Gibson, R.A., Determination of the optimal ratio of linoleic acid to alpha-linolenic acid in infant formulas, J. Pediatr., 4, S151-S158, 1992.
45. Clandinin, M.T., Van Aerde, J.E., Parrott, A., Field, C.J., Euler, A.R., and Lien, E., Assessment of feeding different amounts of arachidonic and docosahexaenoic acids in preterm infant formulas on the fatty acid content of lipoprotein lipids, Acta Pediatr., 88, 890-896, 1999.
46. Nair, S.S.D., Leitch, J.W., Falconer, J., and Garg, M.L., Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action, J. Nutr., 127, 383-393, 1997.
47. Simopoulos, A.P., ω-3 Fatty acids in the prevention-management of cardiovascular disease, Can. J. Physiol. Pharmacol., 75, 234-239, 1997.
48. Uauy-Dagach, R. and Valenzuela, A., Marine oils: the health benefits of n-3 fatty acids, Nutr. Rev., 54, S102-S108, 1996.
49. Simon, J.A., Hodgkins, M.L., Browner, W.S., Neuhaus, J.M., Bernert, J.T., Hulley, S.B., Serum fatty acids and the risk of coronary heart disease, Am. J. Epidemiol., 142, 469-476, 1995.
50. Gaudette, D.C. and Holub, B.J., Docosahexaenoic acid (DHA) and human platelet reactivity. J. Nutr. Biochem., 2, 116-121, 1991.
51. Kang, J.X. and Leaf, A., The cardiac antiarrhythmic effects of polyunsaturated fatty acid, Lipids, 31, S41-S44, 1996.
52. Grimsgaard, S., Bonaa, K.H., Hansen, J.B., and Nordoy, A., Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids, Am. J. Clin. Nutr., 66, 649-659, 1997.
53. Mori, T.A., Burke, V., Puddey, I.B., Watts, G.F., O’Neal, D.N., Best, J.D., and Beilin, L.J., Purified eicosapentaenoic and docosahexaenoic acids have different effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men, Am. J. Clin. Nutr., 71, 1085-1094, 2000.
54. Engler, M.M., Engler, M.B., Malloy, M., Chiu, E., Besio, D., Paul, S., Stuehlinger, M., Morrow, J., Ridker, P., Rifai, N., and Mietus-Snyder, M., Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study, Int. J. Clin. Pharm. Therap., 42, 672-679, 2004.
55. Simopoulos, A.P., Leaf, A., and Salem, N., Jr., Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J. Am. Coll. Nutr., 18, 487-489, 1999.
56. Kris-Etherton, P.M. et al., AHA Scientific Statement. Fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease, Circulation, 106, 2747, 2002.
57. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, Department of Health and Human Services (HHS) and U.S. Department of Agriculture (USDA), January 2005.
58. Holub, B.J., Docsahexaenoic acid in human health, in Omega-3 Fatty Acids: Chemistry, Nutrition and Health Effects, Shahidi, F. and Finley, J.W., Eds., American Chemical Society, Washington, DC, 2001, pp. 54-65.
59. Hibbeln, J. and Salem, N., Dietary polyunsaturated fatty acids and depression: when cholestrol does not satisfy, Am. J. Clin. Nutr., 62, 1-9, 1995.
60. Simopoulos, A.P., New products from the agri-food industry: the return of n-3 fatty acids into the food supply, Lipids, 34, S297-S301, 1999.
61. Simopoulos, A.P., n-3 Fatty acids and human health: defining strategies for public policy, Lipids, 36, S83-S89, 2001.
62. Stevens, L.J., Zentall, S.S., Deck, J.L., Abate, M.L., Watkins, B.A., Lipp, S.R., and Burgess, J.R., Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder, Am. J. Clin. Nutr., 62, 761-768, 1995.
63. Champoux, M., Hibbeln, J.R., Shannon, C., Majchrzak, S., Suomi, S.J., Salem, N., Jr., and Higley, J.D., Fatty acid formula supplementation and neuromotor development in rhesus monkey neonates, Pediatr. Res., 51, 273-281, 2002.
64. Moriguchi, T., Greiner, R.S., and Salem, N., Jr., Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration, J. Neurochem., 75, 2563-2573, 2000.
65. Calon, F., Lim, G.P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, O., Triller, A., Salem, N., Jr., Ashe, K.H., Frautschy, S.A., and Cole, G.M., Docosahexaenioc acid protects from dendritic pathology in an Alzheimer’s disease mouse model, Neuron, 43, 633-645, 2004.
66. Lim, G.P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O., Salem, N., Jr., Frautschy, S.A., and Cole, G.M., A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model, J Neurosci., 25, 3032-3040, 2005.
67. Ruyle, M., Connor, W.E., Anderson, G.J., and Lowensohn, R.I., Placental transfer of essential fatty acids in humans: venous-arterial difference for docosahexaenoic acid in fetal umbilical erythrocytes, Proc. Natl. Acad. Sci. USA, 87, 7902-7906, 1990.
68. Cetin, I., Giovannini, N., Alvino, G., Agostoni, C., Riva, E., Giovannini, M., and Pardi, G., Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships, Pediatr. Res., 52, 750-755, 2002.
69. Koletzko, B., Agostoni, C., Carlson, S.E., Clandinin, T., Hornstra, G., Neuringer, M., Uauy, R., Yamashiro, Y., and Willatts, P., Long-chain polyunsaturated fatty acids and perinatal development, Acta Paediatr., 90, 460-464, 2001.
70. Forsyth, J.S., Willatts, P., Agostoni, C., Bissenden, J., Casaer, P., and Boehm, G., Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomized controlled trial, Br. Med. J., 326, 953-957, 2003.
71. Auestad, N., Halter, R., Hall, R.T., Blatter, M., Bogle, M.L., Burks, W., Erickson, J.R., Fitzgerald, K.M., Dobson, V., Innis, S.M., Singer, L.T., Montalto, M.B., Jacobs, J.R., Qiu, W., and Bornstein, M.H., Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study, Pediatrics, 108, 372-381, 2001.
72. Otto, S.J., Houwelingen, A.C.V., and Hornstra, G., Search for an LCP supplement for pregnant women, Prostaglandins, Leukotrienes Essen. Fatty Acids, 57, 190, 1997.
73. Olsen, S.F., Sorensen, J.D., Secher, N.J. et al., Randomised controlled trial of effect of fish oil supplementation on pregnancy duration, Lancet, 339, 1003-1007, 1992.
74. Helland, I.B., Smith, L., Saarem, K., Saugstad, O.D., and Drevon, C.D., Maternal supplementation with very-long-chain fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age, Pediatrics, 111, e39-e44, 2003.
75. Makrides, M. and Gibson, R.A., Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation, Am. J. Clin. Nutr., 71, 307-311, 2000.
76. Jensen, C., Voigt, R., Llorente, A., Peters, S., Prager, T., Zou, Y., Fraley, K., and Heird, W., Effect of maternal docosahexaenoic acid (DHA) supplementation on neuropsychological and visual status of former breast-fed infants, Pediatr. Res., 55, 181A, 2004.
77. Jensen, C., Voigt, R., Prager, T., Zou, Y., Fraley, K., Rozelle, J., Turich, M., Llorente, W., and Heird, W., Effect of maternal docosahexaenoic acid (DHA) supplementation on visual function and neurodevelopment of breast-fed infants, Pediatr. Res., 49, 2572, 2004.
78. Streekstra, H., Fungal production of arachidonic acid-containing oil on an industrial scale, Inform, 15, 20, 21, 2004.
79. Ratledge, C., Yeasts, moulds, algae and bacteria as sources of lipids, in Technological Advances in Improved and Alternative Sources of Lipids, Kamel, B.S and Kakuda, Y., Eds., Blackie, London, 1994, pp. 235-291.
80. Steinbüchel, A., Polyxydroxyalkanoic acids, in Biomaterials, Byrom, D., Ed., McMillan, London, 1991, pp. 123-213.
81. Kavadia, A., Komaitis, M., Chevalot, I., Blanchard, F., Marc, I., and Aggelis, G., Lipid and gammalinolenic acid accumulation in strains of Zygomycetes growing on glucose, J. Am. Oil. Chem. Soc., 78, 341-346, 2001.
82. Matsuo, T., Terashima, M., Hasimoto, Y., and Hasida, W., Method for Producing Cacao Butter Substitute, U.S. Patent 4,308, 350, 1981.
83. Kendrick, A. and Ratledge, C., Lipids of selected molds grown for production of n-3 and n-6 polyunsaturated fatty acids, Lipids, 27, 15-20, 1992.
84. Barclay, W.R., Meager, K.M., and Abril, J.R., Heterotrophic production of long chain omega-3 fatty acids utilizing algae and algae-like microorganisms, J. Appl. Phycol., 6, 123-129, 1994.
85. Spector, D.L., Dinoflagellates, Academic Press, New York, 1984.
86. Harrington, G.W., Beach, D.H., Dunham, J.E., and Holz, G.G., Jr., The polyunsaturated fatty acids of marine dinoflagellates, J. Protozool., 17, 213-9, 1970.
87. Zeller, S., Barclay, W., and Abril, R., Production of docsahexaenoic acid from microalgae, in Omega-3 Fatty Acids: Chemistry, Nutrition and Health Effects, hahidi, F. and Finley, J.W., Eds., American Chemical Society, Washington, DC, 2001, pp. 108-124.
88. Hammond, B.G., Mayhew, D.A., Kier, L.D., Mast, R.W., and Sander, W.J., Safety assessment of DHArich microalgae from Schizochytrium sp., Regulatory Toxicol. Pharmacol., 35, 255-265, 2002.
89. Dembitsky, V.M., Pechenkina-Shubina, E.E., and Rozentsvet, O.A., Glycolipids and fatty acids of some seaweeds and marine grasses from the Black Sea, Phytochemistry, 30, 2279-2283, 1991.
90. Hamanaka, T., Higashiyama, K., Fujikawa, S., and Park, E.Y., Mycelial pellet intrastructure and visualization of mycelia and intracellular lipid in a culture of Mortierella alpine, Appl. Microbiol. Biotechnol., 56, 233-238, 2001.
91. Kyle, D.J., Production and use of a single cell oil which is highly enriched in docosahexaenoic acid, Lipid Technol., 9, 107-110, 1996.
92. Barclay, W.R., Process for Growing Thraustochytrium and Schizochytrium Using Non-Chloride Salts to Produce a Microfloral Biomass Having Omega-3-Highly Unsaturated Fatty Acids, U.S. Patent 5, 340, 742, 1994.
93. Park, E.Y., Koike, Y., Higashiyama, K., Fujikawa, S., and Okabe, M., Effect of nitrogen source on mycelial morphology and arachidonic acid production in cultures of Mortierella alpina, J. Biosci. Bioeng., 88, 61-67, 1999.
94. Eroshin, V.K., Dedyukhina, E.G., Satroutdinov, A.D., and Chistyakova, T.I., Growth-coupled lipid synthesis in Mortierella alpina LPM 301, a producer of arachidonic acid, Microbiology, 71, 169-172, 2002.
95. Schutte, H. and Kula, M.R., Pilot- and process-scale techniques for cell disruption, Biotechnol. Appl. Biochem., 12, 599-620, 1990.
96. Chisti, Y. and Moo-Young, M., Disruption of microbial cells for intracellular products, Enzyme Microbial Technol., 8, 194-204, 1986.
97. Shim, S.M., Santerre, C.R., Burgess, J.R., and Deardorff, D.C., Omega-3 fatty acids and total polychlorinated biphenyls in 26 dietary supplements, J. Food Sci., 68, 2436-2440, 2003.
98. Becker, C.C. and Kyle, D.J. Developing functional foods. Food Technol., 52, 68-71, 1998.
99. Aursand, M., Rainuzzo, J.R., and Grasdalen, H., Quantitative high-resolution C-13 and H-1 nuclear magnetic resonance of omega-3 fatty acids from white muscle of Atlantic salmon (Salmo salar), J. Am. Oil Chem. Soc., 70, 971-981, 1993.
100. Kyle, D.J., The large scale production and use of a single cell oil highly enriched in docosahexaenoic acid, in Omega-3 Fatty Acids. Chemistry, Nutrition and Health Effects, Shahidi, F. and Finely, J.W., Eds., ACS Symposium Series 788, American Chemical Society, Washington, DC, 2001, pp. 92-107.
101. Kritchevsky, D., Tepper, S.A., Czarnecki, S.K., and Kyle, D.J., Effects of 4-methylsterols from algae and of β-sitosterol on cholesterol metabolism in rats, Nutr. Res., 19, 1649-1654, 1999.
102. Myher, J.J., Kuksis, A., Geher, K., Park, P.W., and Diersen-Schade, D.A., Stereospecific analysis of triacylglycerols rich in long-chain polyunsaturated fatty acids, Lipids, 31, 207-215, 1996.
103. Martin, J.C., Bougnoux, P., Antoine, J.M., Lanson, M., and Couet, C., Triacylglycerol structure of human colostrum and mature milk, Lipids, 28, 637-643, 1993.
104. Kurtzweil, P., Taking the fat out of food, FDA Consumer, 30, 7, 1996.
105. U.S. Food and Drug Administration, Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives used in Food, Bureau of Foods, Washington, DC, 1982.
106. U.S. Food and Drug Administration, Department of Health and Human Services, Code of Federal Regulations, Title 21: Food and Drugs, Part 170: Food Additives, U.S. Government Printing Office, Vol. 3, revised as of April 1, 2001, p. 5.
107. Boswell, K., Kosketo, E.K., Carl, L., Glaza, S., Hensen, D.J., Williams, K.D., and Kyle, D.J., Preclinical evaluation of single-cell oils that are highly enriched with arachidonic acid and docosahexaenoic acid, Food Chem. Toxicol., 34, 585-593, 1996.
108. Health and Welfare Canada, Nutrition Recommendations, report of the Scientific Review Committee, Department of Supply and Services, H49-42/1990E, Ottawa, ON, 1990.
109. Farrell, D.J., Enrichment of hen eggs with n-3 long-chain fatty acids and evaluation of enriched eggs in humans, Am. J. Clin. Nutr., 68, 538-44, 1998.
110. Sargent, J.R., McEvoy, L.A., and Bell, J.G., Requirements, presentation and sources of polyunsaturated fatty acids in marine fish larval feeds, Aquaculture, 155, 117-127, 1997.
111. Barclay, W. and Zeller, S., Nutritional enhancement of n-3 and n-6 fatty acids in rotifers and Artemia by feeding spray-dried Schizochytrium sp., J. World Aqua. Soc., 27, 314-322, 1996.